Skip to content
Home/GPs/Revaia
Revaia

Revaia

PARIS, France·Founded 2018··revaia.com

Revaia is a Paris-based growth equity investment fund founded in 2018, focusing on partnering with mission-driven entrepreneurs to support European technology companies from growth stage to IPO or buyout, with a strong emphasis on sustainability and innovation. It manages €600 million in assets and has offices in Paris, Berlin, and London, with a presence in North America.

AUM
€600M
Funds
2
vintages 2021–2024
Portfolio
21
Exits
1
SectorsTMTSoftwareConsumerFinancialsBusiness Services

Key facts

HQPARIS, France
Founded2018
Websiterevaia.com

Recent exits

Hublo
Healthcare · 2025 · 3yr hold

Coverage notes

2 funds tracked, 22 portfolio companies (21 active · 1 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Revaia has raised, with its portfolio companies. Hand-checked from public filings.

2 funds
Revaia Growth II SLPGrowth
2024 · 2yr€250M10 active

Unrealized

10 held
AmpecoActive
ClimateTechBulgaria· Entry 2024
CoralogixActive
TMTIsrael· Entry 2024
DefinelyActive
TMTUK· Entry 2025
IntersecActive
TMTFrance· Entry 2025
KaikoActive
FintechFrance· Entry 2024
MewsActive
TMTCzech Republic· Entry 2024
Sekoia.ioActive
TMTFrance· Entry 2024
SembleActive
HealthcareUK· Entry 2026
SyneraActive
TMTGermany· Entry 2026
TMTFrance· Entry 2024
Revaia Growth I SLPVC
2021 · 5yr€250M11 active · 1 realized

Unrealized

11 held
acornsActive
FintechUS· Entry 2021
AircallActive
TMTFrance· Entry 2021
AlgoliaActive
TMTUS· Entry 2021
DeepkiActive
ClimateTechFrance· Entry 2017
EpsorActive
FintechFrance· Entry 2023
FASSTActive
FintechFrance· Entry 2023
FrontifyActive
TMTSwitzerland· Entry 2022
GetAcceptActive
TMTSweden· Entry 2022
PlanityActive
TMTFrance· Entry 2022
TMTFrance· Entry 2022
YuboActive
TMTFrance· Entry 2021

Realized

1 exit
HubloExited 2025
HealthcareFrance· Entry 2022
Secondaryto
Track Revaia

Saved GPs appear in your watchlist, one click from your workspace.

About Revaia

Revaia is a Paris-based growth equity investment fund with €600 million of assets under management, founded in 2018 and focusing on partnering with mission-driven entrepreneurs to support European technology companies from growth stage to IPO or buyout exit. The growth equity mandate distinguishes Revaia from early-stage VC peers, with the firm investing in profitable scaling tech companies with proven business models.

Investment thesis

Revaia targets European technology companies at growth equity stage with €5 million-plus annual revenue and proven business models, deploying equity tickets typically ranging from €10 million to €40 million per transaction. Sector focus spans HealthTech, enterprise software, fintech and selectively other European tech verticals. The mission-driven entrepreneurship filter aligns Revaia's investment criteria with ESG-conscious limited partners seeking impact-aware growth equity exposure.

Recent activity

Recent realised exits include Hublo (healthcare, 2025), reflecting selective distribution activity across the European tech growth portfolio. The platform tracks 2 funds, 20 active portfolio companies and 1 realised exit across the growth equity programme. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated June 2026 · Sourced from public filings